A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients’ Lives and Allografts
Open Access
- 16 September 2020
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (9), 2986
- https://doi.org/10.3390/jcm9092986
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has posed a significant challenge to physicians and healthcare systems worldwide. Evidence about kidney transplant (KTx) recipients is still limited. A systematic literature review was performed. We included 63 articles published from 1 January until 7 July 2020, reporting on 420 adult KTx recipients with confirmed COVID-19. The mean age of patients was 55 ± 15 years. There was a male predominance (67%). The majority (74%) were deceased donor recipients, and 23% were recently transplanted (<1 year). Most patients (88%) had at least one comorbidity, 29% had two, and 18% three. Ninety-three percent of cases were hospitalized. Among them, 30% were admitted to the intensive care unit, 45% developed acute respiratory distress syndrome, and 44% had acute kidney injury with 23% needing renal replacement therapy. From the hospitalized patients a total of 22% died, 59% were discharged, and 19% were still in hospital at the time of publication. Immunosuppression was reduced in 27%, discontinued in 31%, and remained unchanged in 5%. Hydroxychloroquine was administered to 78% of patients, antibiotics to 73%, and antivirals to 30% while 25% received corticosteroid boluses, 28% received anti-interleukin agents, and 8% were given immunoglobulin. The main finding of our analysis was that the incidence of COVID-19 among kidney transplant patients is not particularly high, but when they do get infected, this is related to significant morbidity and mortality.This publication has 94 references indexed in Scilit:
- Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell TherapyTransplantation and Cellular Therapy, 2018
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- mTOR inhibitors and renal allograft: Yin and YangJournal of Nephrology, 2014
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- Antiretroviral and Immunosuppressive Drug-Drug Interactions in Human Immunodeficiency Virus–Infected Liver and Kidney Transplant RecipientsTransplantation Proceedings, 2009
- Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityTransplant Infectious Disease, 2009
- Infection in Solid-Organ Transplant RecipientsThe New England Journal of Medicine, 2007
- Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular ArrhythmiaClinical Toxicology, 2006
- Acute renal impairment in coronavirus-associated severe acute respiratory syndromeKidney International, 2005